Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in postmenopausal women with hormone-receptor positive early breast cancer from a Canadian perspective (Q80676563)
Jump to navigation
Jump to search
scientific article published on 26 July 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in postmenopausal women with hormone-receptor positive early breast cancer from a Canadian perspective |
scientific article published on 26 July 2007 |
Statements
Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in postmenopausal women with hormone-receptor positive early breast cancer from a Canadian perspective (English)
Thomas E Delea
Khalid El-Ouagari